U.S. regulators recently approved what is being termed the ‘world’s first digital medicine’: a pill with an inbuilt sensor that can be tracked inside the stomach, and communicates data surrounding whether—and when—patients have taken critical medication. The Food and Drug Administration are permitting the device to be used in an antipsychotic medication, with the overall goal of increased medication adherence, and the hope that the data can be used to help both doctors and patients better manage treatment.
Amanda L. Goltz, MPA is the Vice President of Digital Innovation at BTG, a global medtech firm, managing the portfolio of digital initiatives combining clinical interventions, device technology, and digital services to incorporate the patient experience and improve measurable outcomes. Previously, Amanda was the Director of Product Strategy and Innovation at Aetna, sourcing emerging solutions from the digital health and innovative networks marketplace, pairing them with employer clients, and directing implementation of the solutions at scale.
A recent article in Harvard Business Review details the ways in which digital health care can help prevent chronic diseases like diabetes. One of the most expensive and rampant chronic diseases, treatment for diabetes exacts a staggering cost of $245 billion each year, with an estimated 30.3 million people affected.
A number of digital health interventions can be used to address chronic conditions like diabetes, with the ultimate goals of reducing costs, improving patients’ involvement in their own care, and mitigating the overwhelming burden of chronic diseases in the U.S. Most recently, Fitbit has demonstrated its interest in addressing diabetes management, forming partnerships with medical device giant Medtronic and DexCom.
New research indicates that digital health has the potential to save up to $46 billion in annual healthcare spending, according to a new report from IQVIA (Quintiles/IMS Health). Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, describes a new landscape of healthcare, in which a model that looks across five different patient population groups has seen a proven reduction in acute care utilization–typically hospitalization–when consumer mobile apps are used.
“Diabetes prevention, diabetes care, asthma, cardiac rehabilitation, and pulmonary rehabilitation: in each of those five areas we took the results from published research and modeled that to estimate that if these available apps today were used by all patients who could benefit from them, the US healthcare system could save $7 billion per year. So that’s just for five areas. If that level of savings was achievable across all disease areas, we’re looking at annual savings of something like $46 billion.”
Nikhil Krishnan is a research analyst at CB Insights. His research focuses on biotechnology/drug development, digital health, autonomous vehicles, and consumer products. He is a graduate from Columbia University, and has worked at several other startups in the past, including Relationship Science, Global Thermostat, and Uber. His research has been featured several times in the Wall Street Journal, Bloomberg, New York Times, and Reuters.
Nikhil publishes a weekly digital health newsletter, with content focussed on examining how startups and corporations are approaching the intersection of healthcare and technology.
Nikhil will host a session, Healthcare 2.0: Macrotrends Shaping Healthcare Delivery, on Thursday, December 14 (9:05 a.m.) at the upcoming MedTech Impact Expo & Conference. For more information and to review the full agenda, click here.
Medical technology firm Cloud DX recently won the “Bold Epic Innovator Award” through the Qualcomm Tricorder X Prize® contest, with its pioneering innovation the
Vitaliti. An advanced wearable device designed to act as a continuous vital sign monitor, the neckband and earpiece—connected to an advanced mobile app through four interdependent wireless devices—can diagnose up to 16 medical conditions. With the mantra “sophisticated solutions for advanced healthcare providers,” Cloud DX’s overarching mission is to streamline and simplify digital tools that help measure and gauge health and wellness. Through its four fundamental pillars of innovation, collaboration, integration, and transformation, Cloud DX represents the forefront of healthcare: an industry rapidly growing and expanding through invention.
This week, a group of researchers published a new study that demonstrates how a novel brain imaging technique can identify people who have suicidal thoughts, simply by presenting them with certain key words, asking them to reflect on their meanings, and using machine learning to analyze that brain activity.
The results of the study, published in the journal Nature Human Behaviour, challenge the common stereotype that suicidal people could change their perspective if they exerted more effort; the data suggests that suicidal feelings and thoughts are deeply intertwined with the way the brain processes information.
“Suicidality isn’t that you can’t cope with life; it’s that you’ve somehow gotten into a pattern of thinking that leads you to consider suicide,” states Marcel Just, a cognitive neuroscientist and the study’s lead author, and a professor of psychology at Carnegie Mellon University.
ThinAir, a security startup whose mission is to allow organizations to detect and investigate insider threats in seconds, has launched a new interface and impact assessment tool, ThinAir 2.0 – a conversational interface that allows for quick assessments of security incidents and their financial impact. The new tool – which the developer describes as “siri for Security” is among a number of new security technologies being introduced to help combat the data security breach epidemic.
Amy Dixon is a Patient Advocate, Elite Paratriathlete, and motivational speaker, speaking on television and radio and at seminars around the world, on subjects pertaining to triumph over adversity, leadership, team work, rare disease management, patient advocacy, and how to achieve a full life despite devastating setbacks.
Amy lost 98% of her sight due to a rare type of Uveitis (an inflammatory autoimmune eye disease), and now travels the world with her guide dog Woodstock by her side, speaking to groups about her passion for empowering patients to educate and advocate for themselves in the face of illness and disease. She is the Vice President of Glaucoma Eyes International Organization, where she serves as a coach and mentor to many visually impaired athletes, eye disease and autoimmune disease patients, helping them live lives beyond their disability and disease through her vast resources and expertise.
The U.S. Department of Education announced Osso VR as the winner in the EdSim Challenge, which called for virtual reality, video game developer, and educational technology communities to submit concepts for immersive simulations that will prepare students for a globally competitive workforce and spur an ecosystem of virtual and augmented reality technology in education.